Inoculation of two genotypes of Hemobartonella felis (California and Ohio variants) to induce infection in cats and the response to treatment with azithromycin

American Journal of Veterinary Research

Volumn 62, Issue 5, 2001, Pages 687-691

  Westfall, Donald S ^a   Jensen, Wayne A ^b   Reagan, William J ^b,c   Radecki, Steven V ^b   Lappin, Michael R ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b HESKA CORPORATION   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE FOSFATEX; ENROFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL VIRULENCE; CAT DISEASE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; GENOTYPE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HEMOBARTONELLA FELIS; MALE; NONHUMAN;

ANIMALIA; BACTERIA (MICROORGANISMS); FELIS; FELIS CATUS; NEGIBACTERIA;

EID: 0035028569     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2001.62.687     Document Type: Article

References (12)

1. Rikihisa Y, Kawahara M, Wen B, et al. Western immunoblot analysis of Haemobartonella muris and comparison of 16s rRNA gene sequences of H. muris, H. felis, and Eperythrozoon suis. J Clin Microbiol 1997;35:823-829.
2. Foley JE, Harrus S, Poland A, et al. Molecular, clinical, and pathologic comparison of two distinct strains of Haemobartonella felis in domestic cats. Am J Vet Res 1998;59:1581-1588.
3. Messick JB, Berent LM, Cooper SK. Development and evaluation of a PCR-based assay for detection of Haemobartonella felis in cats and differentiation of H. felis from related bacteria by restriction fragment length polymorphism analysis. J Clin Microbiol 1998;36: 462-466.
4. Jensen WA, Lappin MR, Kamkar S, et al. Use of a polymerase chain reaction assay to detect and differentiate two strains of Haemobartonella felis in naturally infected cats. Am J Vet Res 2001;62: 604-608.
5. Berent LM, Messick JB, Cooper SK. Detection of Haemobartonella felis in cats with experimentally induced acute and chronic infections, using a polymerase chain reaction assay. Am J Vet Res 1998;59:1215-1220.
6. VanSteenhouse JL, Taboada J, Millard JR. Feline hemobartonellosis. Compend Contin Educ Pract Vet 1993;15:535-545.
7. Bobade PA, Nash AS, Rogerson P. Feline haemobartonellosis: clinical, haematological and pathological studies in natural infections and the relationship to infection with feline leukaemia virus. Vet Rec 1988;122:32-36.
8. Ishida K, Kaku M, Irifune K. In vitro and in vivo activities of macrolides against Mycoplosma pneumoniae. Antimicrob Agents Chemother 1994;38:790-798.
9. Dunn CJ, Barradell LB. Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections. Drugs 1996;51:483-505.
10. Tarlow MJ, Block SL, Harris J, et al. Future indications for macrolides. Pediatr Infect Dis J 1997;16:457-62.
11. Hunter RP, Lynch MJ, Ericson JF, et al. Pharmacokinetics, oral bioavailability and tissue distribution of azithromycin in cats. J Vet Pharmacol Ther 1995;18:38-46.
12. Harvey JW, Gaskin JM. Experimental feline hemobartonellosis. J Am Anim Hosp Assoc 1977;13:28-38.